Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 619.63 | 487.12 | 455.45 | 396.46 |
Total Revenue | 619.63 | 487.12 | 455.45 | 396.46 |
Costof Revenue Total | 141.04 | 74.18 | 60.30 | 83.75 |
Gross Profit | 478.59 | 412.94 | 395.15 | 312.71 |
Selling/ General/ Admin Expenses Total | 111.47 | 166.11 | 128.40 | 85.27 |
Depreciation/ Amortization | 74.55 | 53.78 | 41.39 | 37.44 |
Other Operating Expenses Total | 222.88 | 123.81 | 135.03 | -119.66 |
Total Operating Expense | 549.93 | 417.88 | 365.11 | 86.79 |
Operating Income | 69.70 | 69.24 | 90.34 | 309.66 |
Interest Inc( Exp) Net- Non- Op Total | -164.88 | 116.89 | -35.81 | -137.15 |
Other Net | 16.80 | -0.90 | 0.00 | 0.01 |
Net Income Before Taxes | 70.01 | 80.20 | 86.51 | 295.45 |
Provisionfor Income Taxes | 13.17 | 18.09 | 18.12 | 110.52 |
Net Income After Taxes | 56.84 | 62.11 | 68.39 | 184.93 |
Net Income Before Extra Items | 56.84 | 62.11 | 68.39 | 184.93 |
Net Income | 56.84 | 62.11 | 68.39 | 184.93 |
Income Availableto Com Excl Extra Ord | 56.84 | 62.11 | 68.39 | 184.93 |
Income Availableto Com Incl Extra Ord | 56.84 | 62.11 | 68.39 | 184.93 |
Diluted Net Income | 56.84 | 62.11 | 68.39 | 184.93 |
Diluted Weighted Average Shares | 3.28 | 3.22 | 2.99 | 3.14 |
Diluted EPS Excluding Extra Ord Items | 17.31 | 19.29 | 22.88 | 58.90 |
DPS- Common Stock Primary Issue | 2.50 | 2.75 | 2.50 | - |
Diluted Normalized EPS | 17.31 | 19.25 | 22.95 | 59.00 |
Gain( Loss)on Saleof Assets | - | 1.76 | -2.48 | -5.06 |
Krsnaa Diagnostics Dividend Krsnaa Diagnostics Bonus Krsnaa Diagnostics News Krsnaa Diagnostics AGM Krsnaa Diagnostics Rights Krsnaa Diagnostics Splits Krsnaa Diagnostics Board Meetings Krsnaa Diagnostics Key Metrics Krsnaa Diagnostics Shareholdings Krsnaa Diagnostics Balance Sheet Krsnaa Diagnostics Cashflow Krsnaa Diagnostics Q1 Results Krsnaa Diagnostics Q2 Results Krsnaa Diagnostics Q3 Results Krsnaa Diagnostics Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks